Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: A phase III randomized study

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 4, 2005, Pages 1014-1020

  Zhao, Kuai Le ^a   Shi, Xue Hui ^a   Jiang, Guo Liang ^a   Yao, Wei Qiang ^a   Guo, Xiao Mao ^a   Wu, Gen Di ^a   Zhu, Long Xiang ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Accelerated hyperfractionation; Chemotherapy; Esophageal carcinoma; Radiation

Indexed keywords

CELLS; CHEMOTHERAPY; DOSIMETRY; IRRADIATION; ONCOLOGY; TOXICITY; TUMORS;

LATE COURSE ACCELERATED HYPERFRACTIONATED (LCAF); MORTALITY; NONSURGICAL MANAGEMENT; SQUAMOUS CELL CARCINOMA (SCC);

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; ESOPHAGUS CARCINOMA; EVALUATION; FEMALE; FRACTIONATION; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 21244497592     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.12.022     Document Type: Article

References (29)

1. L.J. Peters, K.K. Ang, H.K. Thames Jr Accelerated fractionation in the radiation treatment of head and neck cancer Acta Oncol 27 1988 185 194
2. T. Sugawara Multiple fractions per day radiotherapy Its background and current status J Jpn Soc Ther Radiol Oncol 9 1997 263 276
3. H.R. Withers, J.M.G. Taylor, B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
4. X.H. Shi, W.Q. Yao, T.F. Lui Late course accelerated fractionation in radiotherapy of esophageal carcinoma Radiother Oncol 51 1999 21 26
5. C. Han, J. Wan, D.A. Zhou The study of 100 patients with late course accelerated radiotherapy for esophageal carcinoma Chin J Radiat Oncol 6 1997 16 18
6. C. Han, X.R. Yang, X.S. Gao, D.A. Zhou, J. Wan Late course accelerated hyperfractionated radiotherapy for esophageal carcinoma [Abstract] Chin J Radiat Oncol 8 1999 192
7. A. Herskovic, K. Martz, M. Al-sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with esophageal cancer N Engl J Med 326 1992 1593 1598
8. M. Al-sarraf, K. Martz, A. Herskovic Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer, an intergroup study J Clin Oncol 15 1997 277 284
9. B.D. Minsky, D. Neuberg, D.P. Kelsen Neoadjuvant chemotherapy plus concurrent chemotherapy and high dose radiation for squamous cell carcinoma of the esophagus A preliminary analysis of the Phase II Intergroup Trial 0122 J Clin Oncol 14 1996 149 155
10. B.D. Minsky, D. Neuberg, D.P. Kelsen Final report of Intergroup Trial 0122 (ECOG PF-289, RTOG 90-12) Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous-cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 43 1999 517 523
11. L.E. Gaspar, K. Winter, W.I. Kocha A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) Cancer 88 2000 988 995
12. B.D. Minsky, T.F. Pajak, R.J. Ginsberg INT0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
13. Y. Wang, X.H. Shi, S.Q. He Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma Int J Radiat Oncol Biol Phys 54 2002 131 136
14. J.D. Jiang, S.D. Dong The analysis of esophageal cancer patients treated by late course hyperfractionation radiotherapy Chin J Radiat Oncol 10 2001 236 238
15. X.F. Sheng, B.Z. Mei, M.L. Cai Late course accelerated hyperfractionation radiotherapy for middle esophageal carcinoma Clinical phase III trial Chin J Radiat Oncol 7 1998 16 18
16. X.S. Gao, X.Y. Qiao, X.R. Yang Late course accelerated hyperfractionation radiotherapy concomitant with cisplation in patients with esophageal carcinoma Oncol Rep 9 2002 767 772
17. E.A. Poplin, P.S. Khanuja, M.J. Kraut Chemoradiotherapy of esophageal carcinoma Cancer 15 1994 1217 1224
18. M.E.B. Powell, P.J. Hoskin, M.I. Sunders CHART in localized cancer of the esophagus Int J Radiat Oncol Biol Phys 38 1997 133 136
19. B. Jeremic, Y. Shibamoto, L. Acimovic Accelerated hyperfractionated radiation therapy and concurrent 5-fourouracil/cisplatin chemotherapy for locoregional squamous-cell carcinoma of the thoracic esophagus A Phase II study Int J Radiat Oncol Biol Phys 40 1998 1061 1066
20. E. Le Prise, P.L. Etienne, B. Meunier A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1994 1779 1784
21. T.N. Walsh, N. Noonan, D. Hollywood A comparison of multimodality therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
22. J.F. Bosset, M. Gignoux, J.P. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
23. S.G. Urba, M.B. Orringer, A. Turrisi Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
24. J.D. Urschel, H. Vasan A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538 543
25. H. Safran, H. Gaissert, P.J. Hesketh Neoadjuvant paclitaxel, cisplatin and radiation for esophageal carcinoma A phase II study [Abstract] Proc Am Soc Clin Oncol 16 1997 304a
26. C. Blanke, A. Chiappori, B. Epstein A phase II trial of neoadjuvant paclitaxel (T) and cisplatin (P) with radiotherapy followed by surgery (S) and postoperative T with 5-fluorouracil (F) and leucovorin (L) in patients (pts) with locally advanced esophageal cancer (LAEC) [Abstract] Proc Am Soc Clin Oncol 16 1997 283a
27. S. Urba, M. Orringer, M. Iannettoni A phase II trial of preoperative cisplatin, paclitaxel, and radiation therapy (XRT) before trans-hiatal esophagectomy (THE) in patients (Pts) with loco-regional esophageal cancer (CA) [Abstract] Proc Am Soc Clin Oncol 19 2000 248a
28. D.J. Adelstein, T.W. Rice, L.A. Rybicki Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy J Clin Oncol 18 2000 2032 2036
29. J.A. Ajani, G. Walsh, R. Komaki Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction Cancer 100 2004 2347 2354